Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant

NCT03755310 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Suvorexant
DRUG: Placebo

Sponsor

Diego García-Borreguero, MD, PhD

Collaborators

[object Object]